CAIFX
Price
$71.37
Change
+$0.73 (+1.03%)
Updated
Apr 24 closing price
Net Assets
107.13B
CFIHX
Price
$71.42
Change
+$0.73 (+1.03%)
Updated
Apr 24 closing price
Net Assets
107.13B
Ad is loading...

CAIFX vs CFIHX

Header iconCAIFX vs CFIHX Comparison
Open Charts CAIFX vs CFIHXBanner chart's image
American Funds Capital Income Bldr F2
Price$71.37
Change+$0.73 (+1.03%)
VolumeN/A
Net Assets107.13B
American Funds Capital Income Bldr F3
Price$71.42
Change+$0.73 (+1.03%)
VolumeN/A
Net Assets107.13B
CAIFX vs CFIHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CAIFX vs. CFIHX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAIFX is a Buy and CFIHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CAIFX (107B) and CFIHX (107B) have equal amount of cash in the bank . CFIHX (3.47) and CAIFX (3.37) have matching dividends . CAIFX was incepted earlier than CFIHX: CAIFX (17 years) vs CFIHX (8 years). CAIFX (0.38) is less costly to investors than CFIHX (0.27). CAIFX has a lower initial minimum investment than CFIHX: CAIFX (250) vs CFIHX (1000000). CFIHX (9.26) and CAIFX (9.13) have marching annual gain over last year. CFIHX (46.16) and CAIFX (45.58) have equivalent 5 years return.
CAIFXCFIHXCAIFX / CFIHX
Total Expense Ratio0.380.27141%
Annual Report Gross Expense Ratio0.380.27141%
Fund Existence17 years8 years-
Gain YTD2.6082.64898%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets107B107B100%
Annual Yield % from dividends3.373.4797%
Returns for 1 year9.139.2699%
Returns for 3 years13.9114.2298%
Returns for 5 years45.5846.1699%
Returns for 10 years33.17N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRI1.820.37
+25.52%
GRI Bio Inc.
MYO4.650.16
+3.56%
Myomo
DRS35.940.80
+2.28%
Leonardo DRS
DNLI14.870.27
+1.85%
Denali Therapeutics
PRTA9.590.05
+0.52%
Prothena Corp